Test Price
2,800 AED✅ Home Collection Available
FOXN1 Gene Analysis for T‑Cell Immunodeficiency, Alopecia, and Nail Dystrophy in UAE | 2800 AED | DHA Licensed
ISO Accredited ProcessingExecutive Summary & Core Metrics
Executive Summary – Key Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited NGS Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (daily 8 AM–11 PM).
- Clinical Guidance: Telephonic Post‑Test Interpretation and Genetic Counseling available.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning ICT in Health Fields, and Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
The FOXN1 gene test utilises Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with T‑cell immunodeficiency, congenital alopecia, and nail dystrophy. This full‑gene coverage approach provides a diagnostic sensitivity of 99.9% and identifies both known and novel mutations, enabling early clinical intervention and informed genetic counselling.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method | NGS (Full Gene Coverage) | Sanger (Selected Exons Only) |
| Sensitivity | 99.9% (LOINC 85399‑6) | ~95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2,800 AED | ~2,500 AED |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I stress that FOXN1 analysis is a powerful diagnostic tool, but results must always be interpreted alongside clinical findings and family history. Early identification of mutations can guide life‑saving treatments, yet variants of uncertain significance warrant careful genetic counselling. No clinical decision should be made solely on genetic data.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA ID: 9294403
⚠ Medication Advisory
Do not stop or alter any prescribed medications without consulting your treating physician. This test is a diagnostic aid and does not replace ongoing clinical management or therapeutic adjustments.
⚠ Safety Exclusions & Emergency Red Flags
- Exclusion Criteria: Active bleeding disorders contraindicating blood draw. For minors, parental consent is mandatory.
- Alternative DNA Sources: Extracted DNA or FTA cards are accepted.
- Emergency Red Flags: Severe infections, respiratory distress, acute worsening of cutaneous or nail symptoms, or signs of immunodeficiency crisis require immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does the FOXN1 genetic test detect?
It identifies pathogenic variants in the FOXN1 gene linked to T‑cell immunodeficiency, congenital alopecia, and nail dystrophy. The test enables early diagnosis and targeted management of these inherited conditions.
2. How long does it take to receive results?
The turnaround time is 3–4 weeks, covering NGS sequencing, bioinformatics analysis, and clinical interpretation by our ISO‑accredited laboratory team.
3. Is home sample collection available in the UAE?
Yes, our VIP mobile phlebotomy service provides hospital‑grade blood or DNA collection at your doorstep from 8 AM to 11 PM, with cold‑chain transport to our Dubai Healthcare City facility.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under the oversight of the Dubai Health Authority (DHA License No. 1143) and adheres to:
- Federal Decree‑Law No. 45 of 2021 – Personal Data Protection Law (PDPL).
- Federal Law No. 2 of 2019 – Use of Information and Communication Technology in Health Fields.
- Federal Decree‑Law No. 4 of 2016 – Medical Liability and Patient Safety.
- ISO 9001:2015 Quality Management System (Cert: INT/EGQ/2509DA/3139).
All genetic data is encrypted and handled in compliance with UAE privacy regulations.
Clinical & Logistical Metadata
| Test Name | FOXN1 Gene Analysis (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coverage |
| ICD‑10‑CM Code | D84.9 (Immunodeficiency, Unspecified) – also L65.0, L60.8 |
| LOINC Code | 85399‑6 (Genetic Analysis – Sequencing) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians